Jounce Therapeutics
Utility Patents
Last updated:
List of all Jounce Therapeutics patents 7 in total
| Status | Patent |
|---|---|
Grant | Utility: Antibodies to LILRB2 Filling date: 6 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Methods of treating cancer in a subject having elevated ICOS and/or T-bet levels of CD+4 cells by administering an ICOS agonist Filling date: 6 Sep 2025 Issue date: 5 Apr 2022 |
Grant | Utility: Gene signatures for determining ICOS expression Filling date: 6 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Antibodies to LILRB2 Filling date: 6 Sep 2025 Issue date: 28 Jul 2020 |
Grant | Utility: Antibodies to PD-1 and uses thereof Filling date: 6 Sep 2025 Issue date: 19 May 2020 |
Grant | Utility: Methods of treating conditions with antibodies that bind B7-H4 Filling date: 6 Sep 2025 Issue date: 21 Apr 2020 |
Grant | Utility: Antibodies to ICOS Filling date: 6 Sep 2025 Issue date: 25 Feb 2020 |
Showing 1 to 7 of 7 patents.